Aprea Therapeutics (APRE) Registration Filing summary

Company overview and business model

• Incorporated in Delaware with principal executive offices in Doylestown, PA.

• Engaged in the biotechnology sector, as indicated by the management and board composition.

Risk factors and disclosures

• Independent auditor's report includes substantial doubt about the company's ability to continue as a going concern.

Management team and governance

• Led by President and CEO Oren Gilad, Ph.D., with John P. Hamill as CFO.

• Board includes directors with medical and scientific backgrounds, such as Rifat Pamukcu, M.D., and Richard Peters, M.D., Ph.D.